- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.01. | JPM: AbbVie pays $650m upfront for RemeGen cancer drug | ||
| 12.01. | FDA removes barriers to cell, gene therapy development | ||
| 12.01. | Abivax climbs on Lilly takeover speculation | ||
| 12.01. | Madrigal eyes combination MASH therapy with Pfizer deal | ||
| 12.01. | Perlmutter's Eikon follows the IPO trail | ||
| 09.01. | J&J jumps on the MFN pricing train | ||
| 09.01. | FDA turns down Hetlioz for jet lag once again | ||
| 09.01. | Now Iktos teams up with Pierre Fabre in oncology | ||
| 09.01. | Parabilis scores $305m in bumper biofinancing week | ||
| 09.01. | Report says MSD is in talks to buy Revolution Meds | ||
| 08.01. | Servier signs €1bn-plus AI pact with Iktos | ||
| 08.01. | Court blocks HHS' 340B rebate programme pilot | ||
| 08.01. | Study finds weight returns more quickly in GLP-1 users | ||
| 08.01. | Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer | ||
| 08.01. | OpenAI launches ChatGPT Health portal | ||
| 07.01. | Hutchmed scores with drug for rare autoimmune disease | ||
| 07.01. | Is Lilly negotiating to buy Ventyx Bio? | ||
| 07.01. | Bayer's Monsanto sues mRNA COVID-19 vaccine makers | ||
| 07.01. | NICE endorses digital tools for people with asthma | ||
| 07.01. | GSK preps filings for chronic hepatitis B drug bepirovirsen | ||
| 06.01. | Amgen inks $840m takeover of UK's Dark Blue Therapeutics | ||
| 06.01. | Lilly taps Nimbus for another obesity candidate | ||
| 06.01. | Alumis shoots up as its Sotyktu rival aces psoriasis trials | ||
| 06.01. | More details emerge of NHS online hospital due next year | ||
| 06.01. | RNA specialist Ribo files $205m IPO in Hong Kong |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.